SUMO proteins: Guardians of immune system
- PMID: 28919255
- DOI: 10.1016/j.jaut.2017.09.001
SUMO proteins: Guardians of immune system
Abstract
Small ubiquitin-like modifier (SUMO) proteins belong to the ubiquitin-like family and act to change the function of target proteins through post-translational modifications. Through their interactions with innate immune pathways, SUMOs promote an efficient immune response to pathogenic challenge avoiding, at the same time, an excess of immune response that could lead to the development of autoimmune diseases. This report discusses the general functions of SUMO proteins; highlights SUMO involvement in the innate immune response through their role in NF-κB and interferon pathways; the involvement of SUMO proteins in autoimmune diseases; and reviews bacterial, viral, and parasitic interactions with SUMO pathways. In conclusion, we speculate that targeting SUMOs could represent a new therapeutic strategy against infections and autoimmunity.
Keywords: Autoimmunity; Innate immune system; Interferon pathway; NF-κB pathway; Small ubiquitin-like modifier (SUMO) proteins.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
The role of protein SUMOylation in rheumatoid arthritis.J Autoimmun. 2019 Aug;102:1-7. doi: 10.1016/j.jaut.2019.05.006. Epub 2019 May 8. J Autoimmun. 2019. PMID: 31078376 Review.
-
Rhabdoviruses, Antiviral Defense, and SUMO Pathway.Viruses. 2018 Dec 3;10(12):686. doi: 10.3390/v10120686. Viruses. 2018. PMID: 30513968 Free PMC article. Review.
-
Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.Nat Commun. 2014 Jun 19;5:4187. doi: 10.1038/ncomms5187. Nat Commun. 2014. PMID: 24942926
-
Innate link between NF-kappaB activity and ubiquitin-like modifiers.Biochem Soc Trans. 2008 Oct;36(Pt 5):853-7. doi: 10.1042/BST0360853. Biochem Soc Trans. 2008. PMID: 18793150
-
Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection.Rev Med Virol. 2016 Nov;26(6):435-445. doi: 10.1002/rmv.1900. Epub 2016 Aug 22. Rev Med Virol. 2016. PMID: 27550835 Review.
Cited by
-
Targeting epigenetic regulation and post-translational modification with 5-Aza-2' deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy.J Immunother Cancer. 2024 Sep 26;12(9):e008654. doi: 10.1136/jitc-2023-008654. J Immunother Cancer. 2024. PMID: 39326886 Free PMC article.
-
Therapeutic Potential of Targeting the SUMO Pathway in Cancer.Cancers (Basel). 2021 Aug 31;13(17):4402. doi: 10.3390/cancers13174402. Cancers (Basel). 2021. PMID: 34503213 Free PMC article. Review.
-
Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts.Respirology. 2022 Sep;27(9):730-738. doi: 10.1111/resp.14302. Epub 2022 Jun 7. Respirology. 2022. PMID: 35673765 Free PMC article.
-
Proteomic Analysis Identifies Molecular Players and Biological Processes Specific to SARS-CoV-2 Exposure in Endothelial Cells.Int J Mol Sci. 2022 Sep 9;23(18):10452. doi: 10.3390/ijms231810452. Int J Mol Sci. 2022. PMID: 36142365 Free PMC article.
-
Different SUMO paralogues determine the fate of wild-type and mutant CFTRs: biogenesis versus degradation.Mol Biol Cell. 2019 Jan 1;30(1):4-16. doi: 10.1091/mbc.E18-04-0252. Epub 2018 Nov 7. Mol Biol Cell. 2019. PMID: 30403549 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical